Sangamo Therapeutics Inc (SGMO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2023 | 03-2023 | 12-2022 | 09-2022 | 06-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -93,373 | 21,133 | -192,278 | -140,305 | -87,150 |
| Depreciation Amortization | 99,383 | 42,671 | 19,320 | 14,798 | 10,148 |
| Income taxes - deferred | -6,377 | N/A | N/A | N/A | N/A |
| Accounts receivable | 537 | -3,577 | 1,890 | 1,316 | 71 |
| Other Working Capital | -162,144 | -158,814 | -82,319 | -64,473 | -51,567 |
| Other Operating Activity | 34,963 | 32,287 | 29,760 | 22,086 | 15,538 |
| Operating Cash Flow | $-127,011 | $-66,300 | $-223,627 | $-166,578 | $-112,960 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 93,936 | 45,928 | 79,456 | 29,369 | 38,418 |
| PPE Investments | -15,740 | -10,200 | -20,171 | -12,697 | -8,284 |
| Investing Cash Flow | $78,196 | $35,728 | $59,285 | $16,672 | $30,134 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 15,824 | 9,111 | 86,764 | 67,087 | 23,134 |
| Other Financing Activity | -1,303 | -1,109 | -2,104 | -1,962 | -1,827 |
| Financing Cash Flow | $14,521 | $8,002 | $84,660 | $65,125 | $21,307 |
| Exchange Rate Effect | 680 | 367 | 1,254 | 479 | 352 |
| Beginning Cash Position | 101,944 | 101,944 | 180,372 | 180,372 | 180,372 |
| End Cash Position | 68,330 | 79,741 | 101,944 | 96,070 | 119,205 |
| Net Cash Flow | $-33,614 | $-22,203 | $-78,428 | $-84,302 | $-61,167 |
| Free Cash Flow | |||||
| Operating Cash Flow | -127,011 | -66,300 | -223,627 | -166,578 | -112,960 |
| Capital Expenditure | -15,740 | -10,200 | -20,171 | -12,697 | -8,284 |
| Free Cash Flow | -142,751 | -76,500 | -243,798 | -179,275 | -121,244 |